In mammals, Galectin-9 could inhibit TLR7-mediated autoimmunity in murine lupus models (37) and suppress the apoptosis in human rheumatoid arthritis synovial fibroblasts (38). The gene discussed is LGALS9; the disease is systemic lupus erythematosus.